SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Alaska Permanent Fund Corp

(Last)

(First)

(Middle)

801 WEST 10TH STREET

SUITE 302

(Street)

JUNEAU

99801

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/13/2020

3. Issuer Name and Ticker or Trading Symbol
Codiak BioSciences, Inc. [ CDAK ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	63,963	I	See footnotes⁽¹⁾⁽²⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A redeemable convertible preferred stock	⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	2,616,093⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	I	See footnotes⁽²⁾⁽⁵⁾
Series B redeemable convertible preferred stock	⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	467,541⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	I	See footnote⁽⁶⁾
Series B redeemable convertible preferred stock	⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	748,061⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	I	See footnotes⁽²⁾⁽⁵⁾
Series C redeemable convertible preferred stock	⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	191,992⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	I	See footnote⁽⁶⁾
Series C redeemable convertible preferred stock	⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	191,992⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	I	See footnotes⁽²⁾⁽⁷⁾

Explanation of Responses:

1. The shares are held by ARCH Venture Fund VIII, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII, L.P..

2. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of its pecuniary interest therein and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose.

3. All shares of Series A redeemable convertible preferred stock, par value $0.0001 per share, Series B redeemable convertible preferred stock, par value $0.0001 per share, and Series C redeemable convertible preferred stock, par value $0.0001 per share, have no expiration date and will automatically convert into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering ("IPO"). Each share of Series A Preferred Stock is convertible into Common Stock on a 1-for-7.8170 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO.

4. Each share of Series B Preferred Stock is convertible into Common Stock on an approximately 1-for-7.1295 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO. Each share of Series C Preferred Stock is convertible into Common Stock on an approximately 1-for-6.8758 basis into the aggregate number of shares of Common Stock shown in Column 3 without payment or further consideration upon closing of the IPO.

5. The shares are held by ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in each of ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P..

6. The shares are held by Yukon Investors, LLC. The Reporting Person holds an interest in Yukon Investors, LLC.

7. The shares are held by ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII Overage, L.P..

Remarks:

The Reporting Person is the Alaska Permanent Fund Corporation, acting for and on behalf of the funds which the Alaska Permanent Fund Corporation is designated by Alaska Statutes 37.13 to manage and invest.

	/s/ Angela Rodell, Chief Executive Officer	10/13/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.